Jan 11 (Reuters) - Zhejiang Hisoar Pharmaceutical Co Ltd :
* Says its pharma unit passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years since 2017
Source text in Chinese: goo.gl/Zi65ck
Further company coverage: (Beijing Headline News)
Our Standards: The Thomson Reuters Trust Principles.